Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.33 +0.12 (+5.49%)
As of: Sep 30, 2026 · 11:49 AM EDT

Xtl Biopharmaceuticals Ltd (XTLB) EBT Margin (2011 - 2024)

Updated

Xtl Biopharmaceuticals' EBT Margin was 202.42% in the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals Ltd (XTLB) EBT Margin (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, EBT Margin at Xtl Biopharmaceuticals came in at 53.22%.

  • EBT Margin shows a four-year change of +7162.31 percentage points (years ended Dec 2020 to Dec 2024).
  • In earlier years, EBT Margin was -7109.09% in the year ended Dec 31, 2020.
  • The figure for the quarter ended Dec 31, 2024 marks the highest quarterly EBT Margin in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 202.42%
Dec 31, 2020 -2,141.67%
Mar 31, 2020 -3,671.43%
Sep 30, 2014 -107.67%
Jun 30, 2014 -186.84%
Mar 31, 2014 -100.00%
Dec 31, 2013 103.09%
Sep 30, 2013 181.18%
Jun 30, 2013 -191.21%
Mar 31, 2013 -132.54%
Dec 31, 2012 65.21%
Sep 30, 2012 -232.94%
Jun 30, 2012 -147.58%
Mar 31, 2012 31.32%
Dec 31, 2011 -29.29%
Sep 30, 2011 -113.99%
Jun 30, 2011 -67.79%
API Access

Xtl Biopharmaceuticals Ltd EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY